BioServe: Cancer Genetics acquires India’s BioServe Biotechnologies

Cancer Genetics, Inc. ("CGI" or the "Company"), a DNA-based diagnostics company focused on developing genomic-based oncology tests and services, today reported financial results for the first quarter ended March 31, 2014, and announced an agreement to acquire BioServe Biotechnologies (India) Pvt. Ltd. for approximately $1.9 million primarily in CGIX stock and other deferred consideration. The […]The post Cancer Genetics acquires India’s BioServe Biotechnologies appeared first on Deal Feed International.